Analysis of pan-cancer RNA sequencing data from The Cancer Genome Atlas (TCGA) showed that RNF220 was upregulated in most tumor tissues, with particularly significant upregulation observed in both AML and acute lymphoblastic leukemia (ALL) (Figure 1a). Here, RNF220 is linked to cancer.